PembrolizumabEosinophilic asthma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1911卷 / 1期

关键词：

D O I：

10.1007/s40278-022-17638-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：341 / 341

相关论文

共 50 条

[1] Budesonide/formoterol/pembrolizumabEosinophilic asthma, sarcoidosis and lack of efficacy : case report
Reactions Weekly, 2023, 1965 (1) : 132 - 132
[2] PembrolizumabEosinophilic pneumonia: case report
Reactions Weekly, 2025, 2040 (1) : 814 - 814
[3] PembrolizumabEosinophilic fasciitis: case report
Reactions Weekly, 2023, 1944 (1) : 471 - 471
[4] PembrolizumabEosinophilic fasciitis: case report
Reactions Weekly, 2021, 1852 (1) : 354 - 354
[5] PembrolizumabEosinophilic pneumonia: case report
Reactions Weekly, 2022, 1930 (1) : 463 - 463
[6] PembrolizumabEosinophilic fasciitis and off label use: case report
Reactions Weekly, 2021, 1872 (1) : 414 - 414
[7] PembrolizumabEosinophilic fasciitis and immune-mediated myositis: case report
Reactions Weekly, 2023, 1970 (1) : 234 - 234
[8] PembrolizumabEosinophilic fasciitis
Reactions Weekly, 2024, 2016 (1) : 410 - 410
[9] AdalimumabFirst report of asthma: case report
Reactions Weekly, 2005, 1078 (1) : 7 - 7
[10] PropylthiouracilFirst report of asthma: case report
Reactions Weekly, 2004, 1020 (1) : 12 - 12

← 1 2 3 4 5 →